• 1
    Presti JC, O'Dowd GL, Miller MC, Mattu R, Veltri RW. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol 2003; 169: 125129
  • 2
    Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for the diagnosing carcinoma of the prostate. J Urol 1997; 157: 199202
  • 3
    Ravery V, Goldblatt L, Royer B et al. Extensive biopsy protocol improves the detection rate of prostate cancer. J Urol 2000; 164: 393396
  • 4
    Ayres B, Montgomery B, Barber N et al. The role of transperineal template prostate biopsies in restaging men with prostate cancer managed by active surveillance. BJU Int 2011; 109: 11701176
  • 5
    Challacombe B, Dasgupta P, Patel U, Amoroso P, Kirby R. Recognizing and managing the complications of prostate biopsy. BJU Int 2011; 108: 12331234
  • 6
    Nam RK, Saskin R, Lee Y et al. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 2010; 183: 963968
  • 7
    Rosario DJ, Lane JA, Metcalfe C et al. Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study. BMJ 2012; 9: 344
  • 8
    Loeb S, van den Heuvel S, Zhu X et al. Infectious complications and hospital admissions after prostate biopsy in a European randomized trial. Eur Urol 2012; 61: 11101114
  • 9
    Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM. Complications after prostate biopsy: data from SEER-Medicare. J Urol 2011; 186: 18301834
  • 10
    Pinkstaff DM, Igel TC, Petrou SP et al. Systematic transperineal ultrasound guided template biopsy of the prostate: three year experience. Urology 2005; 65: 735739
  • 11
    Satoh T, Matsumoto K, Fujita T et al. Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy. Urology 2005; 66: 114118
  • 12
    Moran BJ, Braccioforte MH, Conterato DJ. Re-biopsy of the prostate using a stereotactic transperineal technique. J Urol 2006; 176: 13761381
  • 13
    Crawford ED, Rove KO, Barqawi AB et al. Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens. Prostate 2013; 73: 778787
  • 14
    Barzell WE, Whitmore WF. Transperineal template guided saturation biopsy of the prostate: rationale, indications, and technique. Urol Times 2003; 31: 4142
  • 15
    Bott SR, Henderson A, Halls JE et al. Extensive transperineal template biopsies of prostate: modified technique and results. Urology 2006; 68: 10371041
  • 16
    Singh PB, Dalton E, Ahmed HU et al. Distribution of prostate cancer on template prostate mapping (TPM) biopsies in men with low volume prostate cancer on transrectal ultrasound (TRUS) biopsies. BJU Int 2011; 108 (Suppl.): 44
  • 17
    Patel V, Merrick GS, Allen ZA et al. The incidence of transition zone prostate cancer diagnosed by transperineal template guided mapping biopsy: implications for treatment planning. Urology 2011; 77: 11485
  • 18
    Acher PL, Dasgupta P, Popert R. Improving prostate brachytherapy by developing image guidance. BJU Int 2007; 99: 10661071
  • 19
    Kasivisvanathan V, Dufour R, Moore CM et al. Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer. J Urol 2013; 189: 860866
  • 20
    Kinsella J, Vyas L, Challacombe B et al. As part of an active surveillance protocol transperineal saturation prostate biopsies do not compromise radical prostatectomy. J Urol 2012; 187 (Suppl): e143144
  • 21
    National Institute for Health and Clinical Excellence. Prostate Cancer: Diagnosis and Treatment CG58. London: National Institute for Health and Clinical Excellence, 2008: 1011
  • 22
    Klotz L. Active surveillance for prostate cancer: patient selection and management. Curr Oncol 2010; 2: S1117